Vanderbilt CDTR Pilot & Feasibility Home Page »

Record History
Added on January 27, 2016 at 8:52 AM by Ray, Terri
Modified on January 27, 2016 at 9:50 AM by Ray, Terri
Shared with (contributions)
CDTR: CDTR Pilot & Feasibility Master
Gurjeet Birdee, M.D., MPH
 Mind-body practices for patients with metabolic syndrome
There is a growing prevalence of metabolic syndrome in the U.S. which is related to poor health behaviors including physical inactivity and unhealthy diets. Mind-body practices are a novel intervention for patients with metabolic syndrome. The project will methodically translate and evaluate a common mind-body practice, yoga, for metabolic syndrome which may lead to new therapeutic options.
Want to know more about Dr. Birdee?
Shelagh Mulvaney, Ph.D.
Promoting Parental Problem Solving and Communication in Adolescent Diabetes
Adolescents with type 1 diabetes are at high risk for poor adherence and glycemic control. In order to address the needs of adolescents with type 1 diabetes, parents, and clinics, Dr. Mulvaney and her team have created an accessible and engaging internet adherence support intervention, named YourWay. The project will integrate two parallel websites, one for adolescents, and one for parents, to teach problem solving skills. Adolescents and parents will communicate via online problem solving cycles, which promote adolescent and parent communication and collaboration to solve adolescent problems.
Want to know more about Dr. Mulvaney?
Chandra Osborn, Ph.D., MPH
Design & Feasibility of a Patient Portal and Mobile Device-delivered Intervention
Although medications improve glycemic control, patient adherence to diabetes medications is often suboptimal. In other chronic disease contexts, health information technologies (HIT) have successfully delivered medication adherence-related information, motivation, and behavioral skills content that has resulted in improvements in medication adherence and clinical outcomes. This project will result in the design of a HIT delivered medication adherence intervention for patients with T2DM and test its feasibility.

Want to know more about Dr. Osborn?